阿尔茨海默病的主动免疫治疗策略与疫苗研发
被引量:3
摘要
阿尔茨海默病(Alzheimer’s disease,AD)是引起痴呆的最常见疾病,以进行性记忆力和认知功能下降为主要临床表现。随着人口老龄化进程,该病引起越来越多的医学界及全社会的关注。众所周知,AD核心神经病理学改变包括细胞外β淀粉样蛋白(Aβ)沉积形成的老年斑以及细胞内由异常磷酸化tau蛋白聚合而成的神经原纤维缠结。
出处
《中华神经科杂志》
CAS
CSCD
北大核心
2011年第9期587-589,共3页
Chinese Journal of Neurology
参考文献24
-
1Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer' s disease: progress and problems on the road to therapeutics. Science, 2002, 297:353-356.
-
2Wilcock DM, Gharkholonarehe N, Van Nostrand WE, et al. Amyloid reduction by amyloid-beta vaccination also reduces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer' s disease. J Neurosci, 2009, 29 : 7957-7965.
-
3Wilcock DM, Colton CA. Anti-amyloid-beta immunotherapy in Alzheimer' s disease: relevance of transgenic mouse studies to clinical trials. J Alzheimers Dis, 2008, 15:555-569.
-
4Orgogozo JM, Gilman S, Dartigues JF, et al. Subacute meningoencephalitis in a subset of patients with AD after Abeta 42 immunization. Neurology, 2003, 61:46-54.
-
5Nicoll JA, Wilkinson D, Holmes C, et al. Neumpathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med, 2003, 9:445-452.
-
6Holmes C, Boche D, Wilkinson D, et al. Long-term effects of Abeta42 immunisation in Alzheimer' s disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet, 2008, 372:216-223.
-
7Tabira T. Immunization therapy for Alzheimer disease: comprehensive review of active immunization strategies. Tohoku J Exp Med, 2010, 220:95-106.
-
8Gilman S, Koller M, Black RS, et al. Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology, 2005, 64:1553-1562.
-
9Vellas B, Black R, Thai LJ, et al. Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders. Curr Alzheimer Res, 2009, 6:144-151.
-
10Monsonego A, Zota V, Karni A, et al. Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease. J Clin Invest, 2003, 112:415-422.
同被引文献40
-
1刘硕,胡雅儿,夏宗勤.小鼠脑内注射Aβ_(25-35)记忆和M受体变化及梓醇的调节作用[J].上海交通大学学报(医学版),2007,27(8):945-948. 被引量:11
-
2Fukami S, Watanabe K, lwata N, et al. Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptie and axonal localization inversely correlating with Abeta pathology. Neurosci Res, 2002, 43: 39-56.
-
3Marr RA, Rockenstein E, Mukherjee A, et al. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J Neurosci, 2003, 23 : 1992-1996.
-
4Marr RA, Guan H, Rockenstein E, et al. Neprilysin regulates amyloid Beta peptide levels. J Mol Neurosci, 2004, 22 : 5-11.
-
5Spencer B, Malt RA, Gindi R, et al. Peripheral delivery of a CNS targeted, metalo-protease reduces a β toxicity in a mouse model of Alzheimer' s disease. PIoS One, 2011. 6: el6575.
-
6Hemming ML, Patterson M, Reske-Nielsen C, et al. Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta- degrading protease: a novel therapeutic approach 1o Alzheimer disease. PloS Med, 2007, 4: 1405-1416.
-
7Guan H, Liu Y, Daily A, et al. Peripherally expressed neprilysin reduces brain amyloid burden: a novel approach for treating Alzheimer' s disease. J Neurosei Res, 2009, 87: 1462-1473.
-
8Park D, Joo SS, Kim TK. et al. Human neural slem cells overexpressing choline acetyhransferase restore cognitive function of kainic acid-induced learning and memory deficit animals. Cell Transplant, 2012, 21: 365-371.
-
9Kanninen K, Heikkinen R, Maim T, el al. Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer' s disease. Proc Nail Acad Sci U S A, 2009, 106: 16505-16510.
-
10Lame ME, Chambers EE, Blamik M. Quantitation of amyloid beta peptides Aβ ( 1-38 ), Aβ ( 1-40 ), and Aβ ( 1-42 ) in humancerebrospinal fluid by ultra-performance liquid chromatography- tandem mass spectrometry. Anal Biochem, 2011,419: 133-139.
引证文献3
-
1黄文,莫雪安,秦超,郑金瓯,梁志坚,程道宾,韦云飞.慢病毒载体介导的neprilysin基因对小鼠神经干细胞的转导及表达[J].中华神经科杂志,2013,46(1):17-21. 被引量:1
-
2宋冲,楚亚楠,贺桂琼,刘刚,王凌晞,周泽芬,姚秋会.梓醇对淀粉样蛋白前体/早老素1双转基因小鼠老年斑和学习记忆的影响[J].中华神经科杂志,2013,46(4):265-268. 被引量:4
-
3李楠,王建平.人源性阿尔茨海默病噬菌体单链抗体库的构建[J].中华老年心脑血管病杂志,2015,17(11):1197-1200.
二级引证文献5
-
1辛佳蔚,章军建,杨英,邓敏,谢晓峰.神经发生对成年大鼠空间学习记忆的影响[J].中华神经科杂志,2014,47(1):45-48. 被引量:1
-
2李海龙,刘敏,张海,郑惠文,周凯歌,王云霞,毕晓莹.Minocycline对血管性抑郁小鼠抑郁行为及神经递质的作用[J].中国卒中杂志,2014,9(12):999-1006. 被引量:5
-
3崔红梅,罗恒,杨军,杨安东.HPLC法同时测定毛果婆婆纳中3种环烯醚萜苷[J].中成药,2015,37(4):810-813. 被引量:8
-
4聂丽霞,刘保江,吕洁萍,杨保仲,付保丽.不同浓度阿片吗啡及蛋脑啡肽对病毒感染细胞生长与凋亡的影响[J].中华医院感染学杂志,2016,26(12):2676-2678. 被引量:1
-
5宋冲,曹斌.梓醇对拟AD模型小鼠小河马突触可塑性的修复作用[J].灾害医学与救援(电子版),2018,7(3):16-16.
-
1金花,姜彩霞,刘跃辉,马骏萍,张东威.脑小血管病诊疗进展[J].临床荟萃,2015,30(2):231-233. 被引量:15
-
2性别与年龄可变更载脂蛋白E与Alzheimer病相关的神经病理学改变[J].现代神经疾病杂志,2002,2(2):71-71.
-
3惠珊,王哲.MicroRNAs与阿尔茨海默病的研究进展[J].中风与神经疾病杂志,2015,32(7):664-666. 被引量:3
-
4性别与年龄可变载脂蛋白E与Alzheimer病相关的神经病理学改变[J].现代神经疾病杂志,2002,2(2):71-71.
-
5牛超群(摘).04084 Affiris在AD疫苗研发方面取得进展[J].国外药讯,2006(4):34-34.
-
6蒋宛霖,孙红斌,杨友松,李小佳,文锦.视神经脊髓炎与多发性硬化关系探讨——(附1例临床及病理报告)[J].中国临床神经科学,2003,11(2):189-190. 被引量:1
-
7付永娟,朴月善,卢德宏.难治性癫的神经病理学特点[J].卒中与神经疾病,2006,13(1):62-64. 被引量:7
-
8乔昕,崔德芝,张恭新,朱振铎.阿尔茨海默病的治疗进展[J].山东医药,2003,43(4):67-68. 被引量:3
-
9陈成雨,刘运振,王衍春,丁福忠,刘宜东.顽固性癫的神经病理学改变[J].中国临床神经科学,2003,11(3):284-285. 被引量:1
-
10陈生弟,任汝静.阿尔茨海默病免疫治疗的前景[J].上海交通大学学报(医学版),2006,26(7):705-707. 被引量:2